Company profileNutraceutical & supplements#719 of 1,318 in Pakistan✓ No DRAP alerts

Vega Nutraceutecal

Nutraceutical & supplement manufacturer · 13 registered products

Ranked #5 of 23 companies in Eye Conditions

13 registered products 15 distinct molecules 0 DRAP alerts
13 of this company's registrations sit in the DRAP category “Eye”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

13
registered products
15
distinct molecules
3
therapeutic classes
0
DRAP alerts

Vega Nutraceutecal is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 13 product registrations. Its portfolio is concentrated in Eye Conditions and Pain Management. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Vega

17 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Pain Management 1

Top molecules by brand count

Therapeutic classes

Eye Conditions · 11Pain Management · 1Allergy · 1

Conditions treated

Allergy/Infections · 5Glaucoma/Mydriasis · 2Dry Eye/Allergy · 2PAIN · 2Pain Killers · 1Conventional Agents · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO4 products · Rs 247 – Rs 1,100
Servaid13 products · Rs 74.75 – Rs 922.88
Median across source: Rs 292.22

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

INNVOTEK PHARMACEUTICALS holds 39 molecules not in this portfolio
AcetazolamideAcyclovirArtemetherAscorbic AcidAzithromycinBisoprolol
VEGA PHARMACEUTICALS LTD. holds 2 molecules not in this portfolio
NepafenacOlopatadine
REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD. holds 59 molecules not in this portfolio
AcetazolamideAcyclovirAmlodipineAmoxicillinAmoxycillin BaseArtemether

Get the full profile for Vega

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.